DOPATREE
Preview
Open in TheBrain
DOPATREE
ORGANIZATIONS
GOVERNMENT ORGANIZATIONS-ALL (GOVT, GOV’T)
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
EXPANDED ACCESS PROGRAMS (EAP, COMPASSIONATE USE, INVESTIGATIONAL NEW DRUG, RESEARCH IND, FOR PATIENTS, PREAPPROVAL, PRE-APPROVED)
EXPANDED ACCESS PROGRAMS / LAWS AND REGULATIONS / US
Parents
EXPANDED ACCESS PROGRAMS (EAP, COMPASSIONATE USE, INVESTIGATIONAL NEW DRUG, RESEARCH IND, FOR PATIENTS, PREAPPROVAL, PRE-APPROVED)
Children
US FDA. DRAFT GUIDANCE. EXPANDED ACCESS TO INVESTIGATIONAL DRUGS FOR TREATMENT USE - QUESTIONS AND ANSWERS. NOV 2022. REV. 1.
US FDA. GUIDANCE. INDIVIDUAL PATIENT EXPANDED ACCESS APPLICATIONS : FORM FDA 3926. OCT 2017.
US FDA. GUIDANCE. INSTITUTIONAL REVIEW BOARD (IRB) REVIEW OF INDIVIDUAL PATIENT EXPANDED ACCESS REQUESTS FOR INVESTIGATIONAL DRUGS AND BIOLOGICAL PRODUCTS DURING THE COVID-19 PUBLIC HEALTH EMERGENCY. JUN 2020.